The pitch, and the protein behind it
The pitch is simple. Prick your finger, mail a card, and learn your "inflammation number." Then check it again, the way you check your steps.
The number is C-reactive protein, or CRP. It is a ring-shaped protein made by your liver, and doctors use it as a marker of inflammation. It can be measured with a standard test or a more sensitive one. The sensitive version, called hs-CRP, is the one used in heart risk research. Doctors use CRP to help diagnose illness, guide treatment and predict disease.
So the number is real. The question is what one reading of it can tell you.
What the number predicts
Here the evidence is strong. In 2024, researchers reported on 27,939 healthy U.S. women whose hs-CRP was measured once and who were then followed for 30 years. Women in the top fifth for hs-CRP had about 1.7 times the risk of a first major heart event, such as a heart attack or stroke, as women in the bottom fifth. For LDL cholesterol, the figure was 1.36. The best risk picture came from looking at hs-CRP, LDL and a blood fat called lipoprotein(a) together.
Two tests on the same person can differ by as much as 71%.From a 2001 review in Ital Heart J
A pooled analysis of 54 long-term studies found the same pattern. Each threefold step up in CRP was linked to about 37% more coronary heart disease, after accounting for the usual risk factors. But CRP was also linked to deaths from some cancers and lung disease, and the authors said the reason was unclear. CRP tells you that something is inflamed. It does not tell you what.
In 2025, the American College of Cardiology said the link between inflammation and heart disease is "compelling and clinically actionable." It noted that in healthy people with high hs-CRP, statins lowered the risk of a first major heart event, even when LDL was normal.
The cut points, and the debate
One common way to read hs-CRP uses three groups: below 1 mg/L is lower risk, 1 to 3 is moderate, and above 3 is higher risk. An earlier review for a U.S. government panel found that people above 3 had about 1.58 times the heart disease risk of people below 1, even after counting the usual risk factors.
Still, experts do not agree on who should be tested. U.S. heart groups cautiously back hs-CRP for people at medium risk. European guidelines advise against routine use for people without heart disease. And that same government review found "limited evidence" that changing your CRP level heads off heart disease.
That gap matters for the "track it like steps" idea. The research shows that a CRP level predicts risk. It does not yet show that watching it go up and down improves your health.
Why one reading can fool you
Your CRP does not sit still. A 2024 review pooled 60 studies that tested the same people more than once. For hs-CRP, the typical swing around a person's own average was about 44%. The authors called this variability "high."
An older review put the swing at about 30% and gave an example of what that means. Two tests on the same person can differ by as much as 71%. It also said a surprise high reading can be checked with a second sample about 2 weeks later.
Some of those surprise highs have a simple explanation. CRP rises with infections and with autoimmune disease. Hard exercise counts too. A review of 28 studies of ultramarathons found that CRP peaked 24 to 72 hours after the race and stayed above baseline for 2 to 3 days. So a test taken the morning after a long race, or during a cold, may be measuring that week, not your usual self.
Does a finger-prick match a blood draw?
Mostly, yes, with a few catches. A 2025 review of dried blood spot tests found that hs-CRP had strong support in both lab and real-world checks. It also said the test has "limited clinical utility."
In one study, 167 adults aged 60 to 96 pricked their own fingers at home three times over about 6 months. They mailed back 493 of 501 expected cards (98%), and 97% of the cards held enough blood to test. The home samples gave steady results over time and lined up strongly with blood drawn from a vein.
The lab method still matters. In a study of 52 matched samples, finger-prick and standard results moved together very closely. But CRP in serum, the liquid part of a standard blood draw, came out about 1.6 times higher than CRP from the dried spot. Dried spot CRP also fell quickly when cards sat at room temperature. A home result is only as good as the way the lab handles and adjusts it.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
your hs-CRP is above 3 on two tests; you have heart disease, diabetes, kidney disease or an autoimmune condition; you are pregnant; you have a fever, an infection or a recent injury; or you are thinking of starting or stopping any medicine because of a home result.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
The protein your liver makes when something is inflamed really does carry a message about your heart. Thirty years of follow-up in thousands of women say so, and a finger-prick card can read it well. But the message is easy to garble. A cold, a long race or a card left sitting out can move the number, and two honest tests can land far apart. So treat hs-CRP like a blood pressure reading, not a step count. Take it when you are well, take it twice, and read it with your doctor next to the rest of your numbers.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 12 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 30, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Randomized trialInflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.Ridker PM, Moorthy MV, Cook NR et al. N Engl J Med, 2024.PubMedFull paper
- Meta-analysisC-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E et al. Lancet, 2010.PubMedFull paper
- Meta-analysisC-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.Buckley DI, Fu R, Freeman M et al. Ann Intern Med, 2009.PubMedFull paper
- ReviewInflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.Mensah GA, Arnold N, Prabhu SD et al. J Am Coll Cardiol, 2026.PubMedFull paper
- ReviewElevated C-reactive protein and cardiovascular risk.Chia JE, Ang SP et al. Curr Opin Cardiol, 2025.PubMedFull paper
- ReviewRole of C-reactive protein in disease progression, diagnosis and management.Ali S, Zehra A, Khalid MU et al. Discoveries (Craiova), 2023.PubMedFull paper
- Meta-analysisWithin-subject variation of C-reactive protein and high-sensitivity C-reactive protein: A systematic review and meta-analysis.Gough A, Sitch A, Ferris E et al. PLoS One, 2024.PubMedFull paper
- ReviewDetermination of the habitual low blood level of C-reactive protein in individuals.Kluft C, de Maat MP et al. Ital Heart J, 2001.PubMed
- Systematic reviewInflammatory Response to Ultramarathon Running: A Review of IL-6, CRP, and TNF-α.Waśkiewicz Z, Mukhambet Z, Azerbayev D et al. Int J Mol Sci, 2025.PubMedFull paper
- Systematic reviewDried Blood Spots to Assess Cardiovascular-Kidney-Metabolic Health.Jacobson TA, Rahbari KJ, Schwartz WA et al. J Am Heart Assoc, 2025.PubMedFull paper
- StudyRemote dried blood spot collection for inflammatory markers in older adults is feasible, reliable, and valid.Reed RG, Hillmann AR, Nation M et al. Brain Behav Immun, 2024.PubMedFull paper
- StudySerum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research.Brindle E, Fujita M, Shofer J et al. J Immunol Methods, 2010.PubMedFull paper




